ArticleMedicine2026
Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential bidirectional causal relationship between endometriosis and serum 25-hydroxyvitamin D has been previously investigated. Nevertheless, the results could be impacted by confounding factors and reverse causality because of the nature of observational research. Mendelian randomization (MR) circumvents the drawbacks of observational studies by providing estimates of unconfounded causal effects. We used bi-directional MR analysis to determine whether serum 25-hydroxyvitamin D had a causal influence on endometriosis and vice versa. Additionally, using heterogeneity and sensitivity analyses, we explored the heterogeneity and pleiotropy of effect estimates. Similarly, we investigated the causal correlation between endometriosis and 25-hydroxyvitamin D through reverse-direction MR. In forward-direction MR, we selected 95 single-nucleotide polymorphisms (SNPs) as instrumental variants (IVs) to examine the potential causal influence between 25-hydroxyvitamin D and endometriosis. And we selected 9 SNPs as IVs for reverse-direction MR analyses to examine whether endometriosis has a causal influence on serum 25-hydroxyvitamin D. We found suggestive evidence that endometriosis contributes to higher serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002-0.02, P = .016). Our data suggest that serum 25-hydroxyvitamin D levels may be a consequence of endometriosis rather than a causal risk factor, and its potential role in the disease process warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.